NCT06359028View on ClinicalTrials.gov

Clinical Study to Evaluate the Anti-sensitivity Efficacy of a Stannous Fluoride Toothpaste in a Population of Dentin Hypersensitivity Sufferers

NACompletedINTERVENTIONAL

Enrollment

111

Participants

Timeline

Start Date

March 25, 2024

Primary Completion Date

June 20, 2024

Study Completion Date

June 20, 2024

Conditions

Dentin Sensitivity

Interventions

DRUG

Stannous fluoride toothpaste

Toothpaste containing 0.454 % weight/weight (w/w) SnF2

DRUG

Crest cavity protection toothpaste

Regular fluoride toothpaste containing 1100 parts per million (ppm) fluoride.

Trial Locations (1)

46825

Salus Research, Fort Wayne

All Listed Sponsors

lead

HALEON

INDUSTRY

NCT06359028 - Clinical Study to Evaluate the Anti-sensitivity Efficacy of a Stannous Fluoride Toothpaste in a Population of Dentin Hypersensitivity Sufferers | Biotech Hunter | Biotech Hunter